Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature's Sunshine Ahead of Key Earnings Reports

Core Insights - Wall Street analysts have raised price targets for Five Below, Ulta Beauty, and Nature's Sunshine ahead of their upcoming earnings reports, indicating confidence in their business momentum and execution [1][2] Group 1: Company Updates - Barclays raised Five Below's price target to $211 from $193, while the stock is currently trading at $219.82, suggesting that much of the positive news may already be priced in [1] - Canaccord Genuity increased Ulta Beauty's target to $799 from $674, with the stock currently at $642.22, reflecting confidence in market share recovery and international expansion [1] - Nature's Sunshine's target was lifted to $29 from $22 by Canaccord, with the stock trading at $25.13, driven by strong digital sales and growth in the Asia-Pacific region [1] Group 2: Recent Performance - Five Below reported a Q3 revenue of $1.038 billion, exceeding estimates by 5.57%, and a comparable sales increase of 14.3% [1] - Ulta Beauty's Q3 revenue reached $2.858 billion, beating estimates by 5.70%, with comparable store sales up 6.3% [1] - Nature's Sunshine achieved Q3 revenue of $128.3 million, surpassing the $120.3 million estimate, with a 42% year-over-year increase in adjusted EBITDA [1] Group 3: Market Context - The timing of the target revisions aligns with the upcoming earnings reports, with Ulta Beauty reporting on March 12, Nature's Sunshine on the same day, and Five Below on March 18 [1] - Ulta Beauty's forward P/E is 23x, Five Below's is 32x, and Nature's Sunshine's is 24x, indicating the premium investors are willing to pay for growth [2] - Nature's Sunshine has a smaller market cap of over $443 million and limited analyst coverage compared to the other two companies [2]